Similar to paxalisib, EVT801 has low toxicity profile and is administered orally. Kazia should be able to take the phase I trial into USA, in addition to Europe.
- Forums
- ASX - By Stock
- KZA
- Ann: Kazia Corporate Presentation
Ann: Kazia Corporate Presentation, page-13
-
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)